Jixian Huang
Shaoguan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Role and mechanism of the CBX4-HDAC5-CERS6 axis in disrupting sphingomyelin metabolism in acute myeloid leukemia.
Journal: American journal of cancer research
Published: August 20, 2025
Overcoming flumatinib resistance in chronic myeloid leukaemia: Insights into cellular mechanisms and ivermectin's therapeutic potential.
Journal: Journal of cellular and molecular medicine
Published: February 15, 2024
Patient Versus Physician Perspective in the Management of Chronic Myeloid Leukemia During Treatment with Tyrosine Kinase Inhibitors.
Journal: Oncology and therapy
Published: September 01, 2023
Integrative Genomic Analysis Reveals Cancer-Associated Gene Mutations in Chronic Myeloid Leukemia Patients with Resistance or Intolerance to Tyrosine Kinase Inhibitor.
Journal: OncoTargets and therapy
Published: April 10, 2020
Clinical characteristics of chronic myeloid leukemia with T315I mutation and the efficacy of ponatinib
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: May 10, 2019
Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 Attenuates Chronic Myeloid Leukemia Chemo-Resistance in Hypoxic Microenvironment.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: February 06, 2018
Therapeutic immune monitoring of CD4+CD25+ T cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
Journal: Oncology letters
Published: October 08, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026